Bing

SEARCH HISTORY

Stock analysts at HC Wainright initiated coverage on shares of Spectrum Pharmaceuticals (NASDAQ:SPPI) in a report issued on Monday, Market Beat.com reports. The firm set a “buy” rating and a $10.00 price target on the biotechnology company’s …
wkrb13.com · 1 day ago
Research analysts at HC Wainright assumed coverage on shares of Spectrum Pharmaceuticals (NASDAQ:SPPI) in a report released on Monday. The firm set a “buy” rating on the biotechnology company’s stock. Shares of Spectrum Pharmaceuticals …
Ticker Report · 6/29/2015
The below chart shows the historical "days to cover" for SPPI at previous short interest release dates: START SLIDESHOW: Top 25 S.A.F.E. Dividend Stocks » An increased "days to cover" value could indicate that …
The Street · 6/26/2015
More from Bing News
Over the last 30 days, the company witnessed two negative estimate revisions and the Zacks Consensus Estimate also moved lower, signaling trouble down the road. So make sure to keep an eye on this stock going forward to see if yesterday’s move …
ZACKS · 5/13/2015
Spectrum Pharmaceuticals, Inc. (SPPI) was a big mover last session, as its shares rose over 10% on the day. The upside came on the back of an encouraging announcement by an activist that the company could fetch more than $7.95 a share in a sale.
Yahoo Finance · 5/13/2015
Spectrum Pharmaceuticals (NASDAQ:SPPI)‘s stock had its “buy” rating restated by analysts at HC Wainright in a research report issued to clients and investors on Friday. Several other analysts have also recently commented on the stock. Analysts at ...
Mideast Times · 6/6/2015
SPPI)’s most prominent drug, Fusilev, to generic competition, the company handed out $2 million in bonuses and salary increments to its top four executives. This came from a company whose stock has slumped by 50% over the last three years, while ...
INSIDER MONKEY · 6/4/2015
Spectrum Pharmaceuticals Inc’s stock traded at artificially inflated prices between August 8, 2012 and March 12, 2013, reaching a high of $13.05 per share on September 18, 2012. Those who purchased shares of Spectrum Pharmaceuticals, Inc. (NASDAQ ...
wallstreetscope.com · 4/29/2015
2015 is unlikely to bring the hopes and dreams of a stock recovery that Spectrum Pharmaceuticals (NASDAQ:SPPI) investors so anxiously desire. In late December, Spectrum filed a new drug application for a product that has created quite a bit of buzz …
Seeking Alpha · 3/10/2015
If you purchased a significant amount of common stock of Spectrum Pharmaceuticals, Inc. (SPPI) between August 8, 2012, and March 12, 2013 and /or if you purchased SPPI shares prior to August 2012 and currently hold any of those shares, you have …
Reuters · 3/20/2013